Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo.
about
Overexpression of the serpin megsin induces progressive mesangial cell proliferation and expansionAngiotensin type 2 receptor actions contribute to angiotensin type 1 receptor blocker effects on kidney fibrosis.Plasminogen activator inhibitor-1 and the kidney.Pleiotropic functions of plasminogen activator inhibitor-1.PAI-1 and atherothrombosis.Plasminogen activator inhibitor-1 is a transcriptional target of the canonical pathway of Wnt/beta-catenin signaling.Therapeutic potential of angiotensin II receptor antagonists.The renin-angiotensin-aldosterone system and vascular remodeling.Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders.The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction.Binge ethanol intake in chronically exposed rat liver decreases LDL-receptor and increases angiotensinogen gene expressionEarly systemic microvascular damage in pigs with atherogenic diabetes mellitus coincides with renal angiopoietin dysbalance.Reduced cardiac expression of plasminogen activator inhibitor 1 and transforming growth factor beta1 in obese Zucker rats by perindopril.Therapeutic approach to FSGS in children.Epistatic effects of polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systems on plasma t-PA and PAI-1 levels.Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsiaRenin angiotensin signaling in normal pregnancy and preeclampsia.Transforming growth factor-beta-dependent and -independent pathways of induction of tubulointerstitial fibrosis in beta6(-/-) mice.Are we content with lowering blood pressure alone, or should we be asking something more from the antihypertensive drugs we use?: effects of antihypertensive agents on fibrinolytic function.Mechanisms of progression of chronic kidney diseaseInternational Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].Protective effects of angiotensin II interruption: evidence for antiinflammatory actions.RAS inhibition in hypertension.Agonists at PPAR-gamma suppress angiotensin II-induced production of plasminogen activator inhibitor-1 and extracellular matrix in rat cardiac fibroblastsEndothelial effects of antihypertensive treatment: focus on irbesartanPAI-1 and kidney fibrosis.The functional role of the renin-angiotensin system in pregnancy and preeclampsia.Endogenous aldosterone contributes to acute angiotensin II-stimulated plasminogen activator inhibitor-1 and preproendothelin-1 expression in heart but not aorta.Inhibition of the renin-angiotensin system and target organ protection.Angiotensin II receptor blockers in the prevention of atrial fibrillation.Loss of heparin-binding protein prevents necrotizing glomerulonephritis: first clues hint at plasminogen activator inhibitor-1.The role of novel biomarkers in predicting diabetic nephropathy: a review.Adiponectin attenuates Ang Ⅱ-induced TGFβ1 production in human mesangial cells via an AMPK-dependent pathway.Renal fibrosis: not just PAI-1 in the sky.Angiotensin II stimulates phosphorylation of an ectodomain-truncated platelet-derived growth factor receptor-beta and its binding to class IA PI3K in vascular smooth muscle cells.Angiotensin II inhibits human trophoblast invasion through AT1 receptor activation.The role of renin angiotensin system inhibition in kidney repair.Overexpression of hepatic plasminogen activator inhibitor type 1 mRNA in rabbits with fatty liver.Tubular cell-enriched subpopulation of primary renal cells improves survival and augments kidney function in rodent model of chronic kidney disease.Short-term effects of exogenous angiotensin II on plasma fibrinolytic balance in normal subjects.
P2860
Q24551372-80EF36BF-BF69-4DB8-8884-0C287F57FC78Q33727750-AC5847CA-A4D7-444D-94BF-F7DCEACDB517Q33960082-BE2B3C02-25AB-495D-B295-E12E8B6ABA52Q33984228-E64DC0C2-9EFD-4ECA-B3D1-41D66FE345E2Q33989347-A8A1C4BF-19C8-4BAD-99CF-A439F21C7C14Q34042645-F2327A92-A2D1-4800-A93C-A8019346B70FQ34481715-6128DF2A-6CF8-49E0-8EF7-95C37C6835ECQ34513169-7DC505AD-5974-492B-8E31-8F9D54B6A308Q35074218-F1AE93C8-7BFB-462E-9B8E-CAD7B72B6F3AQ35148421-F23D0F34-0F1E-4F8B-A726-420556FF9EE1Q35238091-9837AF11-E076-456F-B568-461ABCFB4C21Q35536459-E58C2402-6A99-4119-A641-F7C8E1980B20Q35583438-BA9BB762-C7D9-4049-8FF5-18E59488A8B9Q35614311-17BB3CBF-4853-4789-9AAE-A240A9A4765EQ35658814-A01D3105-1009-4887-B786-D8A7CB0A5106Q35681821-859039BC-6FC6-407A-AF8B-9B4AB928B2C1Q35743816-E20EC7F6-ABD6-40B4-8274-3A0A0E355D14Q35792147-39A9F061-4EFF-4F83-8AB2-4416A246DB41Q35816401-0DB810FD-BEEB-427A-9C21-1068B0C16B6AQ36120044-2023C942-9532-4672-B15C-1931649A9BFAQ36241932-86105762-D30D-4960-B9C1-0E417BE0D2ECQ36257966-2DE26241-8A12-4D26-9519-9D5618F2B6F9Q36362382-C2312378-B554-4A34-B0EA-D1D74848C2D1Q36734442-4B8BD0CD-3D4A-4013-83E1-B8180FD9226DQ36766914-FE1BCA73-D580-42A1-8BE4-42AE1481B9D7Q36846526-1C808BA7-CA9A-4D64-9DBD-4D61771C1293Q37039872-8E23406D-4785-42DC-BFFE-B0CBED5E3456Q37166025-3FCC8F6B-3652-46BF-B4D1-0DAE80CC20D5Q37406883-95B47C56-A374-4AE8-A3C9-ECC5EF01CC65Q37494662-EF843625-373C-4DCA-8EA9-A36D5546F6AFQ38094620-88589AF8-AC2A-4077-9360-642BF33DC14CQ38598929-4E9DE352-B52A-4EC4-A6EF-BD8CE3429B89Q38932521-558F17AC-85C2-434E-9209-A022EE6C31C5Q39793311-0D4FFA90-9E30-41F9-A168-7057F748793CQ40299036-76AD134E-F865-4FF3-85DB-0527A67E56E8Q40735093-6CBD4FDD-6155-4736-A1C5-44500EB7E3DCQ41206891-BF8963DF-F68A-4707-8231-B3D3E8668C72Q41513427-832247A8-368D-49DC-80CE-4AAD642F4242Q42913259-088A540B-19E2-4F43-90D9-E0C52690EFECQ44786125-4EE4C179-9677-443D-97FF-3398037CC732
P2860
Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Plasminogen activator inhibito ...... ensin type 1 receptor in vivo.
@ast
Plasminogen activator inhibito ...... ensin type 1 receptor in vivo.
@en
type
label
Plasminogen activator inhibito ...... ensin type 1 receptor in vivo.
@ast
Plasminogen activator inhibito ...... ensin type 1 receptor in vivo.
@en
prefLabel
Plasminogen activator inhibito ...... ensin type 1 receptor in vivo.
@ast
Plasminogen activator inhibito ...... ensin type 1 receptor in vivo.
@en
P2093
P1433
P1476
Plasminogen activator inhibito ...... ensin type 1 receptor in vivo.
@en
P2093
P304
P356
10.1046/J.1523-1755.2000.00160.X
P407
P577
2000-07-01T00:00:00Z
P5875
P6179
1047583911